Antinociceptive and anti-inflammatory effects of ginsenoside Rf in a rat model of incisional pain

被引:75
作者
Kim, Min Kyoung [1 ]
Kang, Hyun [1 ]
Baek, Chong Wha [1 ]
Jung, Yong Hun [1 ]
Woo, Young Cheol [1 ]
Choi, Geun Joo [1 ]
Shin, Hwa Yong [1 ]
Kim, Kyung Soo [2 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, 201 Heukseok Ro, Seoul 06973, South Korea
[2] Chung Ang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
analgesics; antiinflammatory agents; ginsenosides; pain; postoperative; NECROSIS-FACTOR-ALPHA; INTRATHECAL GINSENOSIDES; POSTOPERATIVE PAIN; TRACE COMPONENT; TOTAL SAPONINS; HYPERALGESIA; ACTIVATION; EXPRESSION; RECEPTORS; INJECTION;
D O I
10.1016/j.jgr.2017.02.005
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Background: Ginseng saponin has long been used as a traditional Asian medicine and is known to be effective in treating various kinds of pain. Ginsenoside Rf is one of the biologically active saponins found in ginseng. We evaluated ginsenoside Rf's antinociceptive and anti-inflammatory effects, and its mechanism of action on adrenergic and serotonergic receptors, in an incisional pain model. Methods: Mechanical hyperalgesia was induced via plantar incision in rats followed by intraperitoneal administration of increasing doses of ginsenoside Rf (vehicle, 0.5 mg/kg, 1 mg/kg, 1.5 mg/kg, and 2 mg/kg). The antinociceptive effect was also compared in a Positive Control Group that received a ketorolac (30 mg/kg) injection, and the Naive Group, which did not undergo incision. To evaluate the mechanism of action, rats were treated with prazosin (1 mg/kg), yohimbine (2 mg/kg), or ketanserin (1 mg/kg) prior to receiving ginsenoside Rf (1.5 mg/kg). The mechanical withdrawal threshold was measured using von Frey filaments at various time points before and after ginsenoside Rf administration. To evaluate the anti-inflammatory effect, serum interleukin (IL)-1 beta, IL-6, and tumor necrotizing factor-alpha levels were measured. Results: Ginsenoside Rf increased the mechanical withdrawal threshold significantly, with a curvilinear dose-response curve peaking at 1.5 mg/kg. IL-1 beta, IL-6, and tumor necrotizing factor-alpha levels significantly decreased after ginsenoside Rf treatment. Ginsenoside Rf's antinociceptive effect was reduced by yohimbine, but potentiated by prazosin and ketanserin. Conclusion: Intraperitoneal ginsenoside Rf has an antinociceptive effect peaking at a dose of 1.5 mg/kg. Anti-inflammatory effects were also detected. (C) 2017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 48 条
[1]
Suppression of MAPKs/NF-βB Activation Induces Intestinal Anti-Inflammatory Action of Ginsenoside Rf in HT-29 and RAW264.7 Cells [J].
Ahn, Sungeun ;
Siddiqi, Muhammad Hanif ;
Aceituno, Veronica Castro ;
Simu, Shakina Yesmin ;
Yang, Deok Chun .
IMMUNOLOGICAL INVESTIGATIONS, 2016, 45 (05) :439-449
[2]
The effects of postoperative pain management on immune response to surgery [J].
Beilin, B ;
Shavit, Y ;
Trabekin, E ;
Mordashev, B ;
Mayburd, E ;
Zeidel, A ;
Bessler, H .
ANESTHESIA AND ANALGESIA, 2003, 97 (03) :822-827
[3]
Increased tumor necrosis factor-α and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia:: The effects of analgesic drugs [J].
Bianchi, Mauro ;
Martucci, Cataldo ;
Ferrario, Paolo ;
Franchi, Silvia ;
Sacerdote, Paola .
ANESTHESIA AND ANALGESIA, 2007, 104 (04) :949-954
[4]
Pregabalin: Dose-Response Relationship in Generalized Anxiety Disorder [J].
Boschen, M. J. .
PHARMACOPSYCHIATRY, 2012, 45 (02) :51-56
[5]
Characterization of a rat model of incisional pain [J].
Brennan, TJ ;
Vandermeulen, EP ;
Gebhart, GF .
PAIN, 1996, 64 (03) :493-501
[6]
Cytokine gene expression in a murine wound healing model [J].
Bryan, D ;
Walker, KB ;
Ferguson, M ;
Thorpe, R .
CYTOKINE, 2005, 31 (06) :429-438
[7]
Choi SS, 2003, PLANTA MED, V69, P1001, DOI 10.1055/s-2003-45145
[8]
Expression of neuron-associated tumor necrosis factor alpha in the brain is increased during persistent pain [J].
Covey, WC ;
Ignatowski, TA ;
Renauld, AE ;
Knight, PR ;
Nader, ND ;
Spengler, RN .
REGIONAL ANESTHESIA AND PAIN MEDICINE, 2002, 27 (04) :357-366
[9]
AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT [J].
COWAN, A ;
LEWIS, JW ;
MACFARLANE, IR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :537-545
[10]
Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy [J].
Cui, JG ;
Holmin, S ;
Mathiesen, T ;
Meyerson, BA ;
Linderoth, B .
PAIN, 2000, 88 (03) :239-248